Ennaid Therapeutics is developing an orally deliverable anti-viral peptide that treats and prevents (much like anti-malarials) Zika virus and has 9+ additional indications to treat and prevent the following viruses: dengue, chikungunya, West Nile, hepatitis c, yellow fever, tick-borne encephalitis, Japanese encephalitis, European encephalitis, Kyasanur Forest virus.